Comparison between whole-body magnetic resonance imaging and whole-body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma

被引:0
|
作者
Rodrigues, Monica Matos Correia [1 ]
Lederman, Henrique Manoel [2 ]
Grossman, Iona [2 ]
Castiglioni, Mario Luiz V. [3 ]
Marchetti, Renata [3 ]
Grass, Daphne Centola [2 ]
Luisi, Flavio Augusto Vercillo [1 ,4 ]
Caran, Eliana Maria Monteiro [1 ]
机构
[1] Univ Fed Sao Paulo, Paulista Sch Med, Support Grp Adolescents & Children Canc, Div Pediat Oncol,Inst Pediat Oncol, Sao Paulo, SP, Brazil
[2] Univ Fed Sao Paulo, Paulista Sch Med, Support Grp Adolescents & Children Canc IOP GRAACC, Div Radiol,Inst Pediat Oncol, Sao Paulo, SP, Brazil
[3] Fed Univ Sao Paulo UNIFESP, Imaging Diagnost Dept DDI, Nucl Med, HU, Sao Paulo, SP, Brazil
[4] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Support Grp Adolescents & Children Canc IOP GRAACC, Div Pediat Oncol,Inst Pediat Oncol, BR-04023062 Sao Paulo, SP, Brazil
关键词
MIBG; MRI; neoplasm staging; neuroblastoma; nuclear medicine; whole-body scintigraphy; DIFFUSION-WEIGHTED MRI; I-123-MIBG SCINTIGRAPHY; DIAGNOSTIC-VALUE; F-18-FDG PET; CHILDREN; DIFFERENTIATION; CT;
D O I
10.1002/pbc.30820
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundWhole-body metaiodobenzylguanidine (131I-MIBG) scintigraphy is the gold standard method to detect neuroblastoma; however, it depends on radioactive material and is expensive. In contrast, whole-body magnetic resonance imaging (WB-MRI) is affordable in developing countries and has been shown to be effective in the evaluation of solid tumors. This study aimed to compare the sensitivity and specificity of WB-MRI with MIBG in the detection of primary tumors and neuroblastoma metastases.ProcedureThis retrospective study enrolled patients with neuroblastoma between 2013 and 2020. All patients underwent WB-MRI and MIBG at intervals of up to 15 days. The results were marked in a table that discriminated anatomical regions for each patient. Two experts evaluated, independently and in anonymity, the WB-MRI images, and two others evaluated MIBG. The results were compared in terms of sensitivity and specificity, for each patient, considering MIBG as the gold standard. This study was approved by the UNIFESP Ethics Committee.ResultsThirty patients with neuroblastoma were enrolled in this study. The age ranged from 1 to 15 years, with a mean of 5.7 years. The interval between exams (WB-MRI and MIBG) ranged from 1 to 13 days, with an average of 6.67 days. Compared to MIBG, WB-MRI presented a sensitivity and specificity greater than or equal to 90% for the detection of primary neuroblastoma in bones and lymph nodes. When we consider the patient without individualizing the anatomical regions, WB-MRI presented sensitivity of 90% and specificity of 73.33%.ConclusionIn conclusion, WB-MRI is a sensitive and specific method to detect neuroblastoma in bone and lymph nodes and highly sensible to primary tumor diagnosis, suggesting that this test is a viable alternative in places where MIBG is difficult to access. Studies with a larger number of cases are necessary for definitive conclusions.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Whole-body MRI of neuroblastoma
    Goo, Hyun Woo
    EUROPEAN JOURNAL OF RADIOLOGY, 2010, 75 (03) : 306 - 314
  • [2] Whole-Body Magnetic Resonance Imaging in Rheumatology
    Chianca, Vito
    Lanckoronski, Micha
    Curti, Marco
    Chalian, Majid
    Sudol-Szopinska, Iwona
    Giraudo, Chiara
    Del Grande, Filippo
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2024, 62 (05) : 865 - 876
  • [3] 123Iodine-metaiodobenzylguanidine scintigraphy versus whole-body magnetic resonance imaging with diffusion-weighted imaging in children with high-risk neuroblastoma - pilot study
    Gassenmaier, Sebastian
    Bares, Roland
    Barreuther, Marcel
    Flaadt, Tim
    Lang, Peter
    Schaefer, Juergen F.
    Tsiflikas, Ilias
    PEDIATRIC RADIOLOGY, 2021, 51 (07) : 1223 - 1230
  • [4] Whole-Body Magnetic Resonance Imaging in Oncology: Uses and Indications
    Petralia, Giuseppe
    Padhani, Anwar R.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2018, 26 (04) : 495 - +
  • [5] Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma
    Lin, Chieh
    Luciani, Alain
    Itti, Emmanuel
    Haioun, Corinne
    Safar, Violaine
    Meignan, Michel
    Rahmouni, Alain
    CANCER IMAGING, 2012, 12 (02): : 403 - 408
  • [6] Whole-Body Magnetic Resonance Imaging for Staging of Lung Cancer
    Puls, Ralf
    Kuehn, Jens-Peter
    Ewert, Ralf
    Hosten, Norbert
    CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 46 - 54
  • [7] The Uses and Limitations of Whole-Body Magnetic Resonance Imaging
    Schmidt, Gerwin
    Dinter, Dietmar
    Reiser, Maximilian F.
    Schoenberg, Stefan O.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2010, 107 (22): : 383 - 389
  • [8] Whole-body magnetic resonance imaging at 0.05 Tesla
    Zhao, Yujiao
    Ding, Ye
    Lau, Vick
    Man, Christopher
    Su, Shi
    Xiao, Linfang
    Leong, Alex T. L.
    Wu, Ed X.
    SCIENCE, 2024, 384 (6696) : eadm7168
  • [9] WHOLE-BODY MAGNETIC RESONANCE IMAGING EVALUATION OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Leung, Doris G.
    Carrino, John A.
    Wagner, Kathryn R.
    Jacobs, Michael A.
    MUSCLE & NERVE, 2015, 52 (04) : 512 - 520
  • [10] Detectability of Malignant Lesions by Whole-Body Magnetic Resonance Imaging Using Whole-Body Integrated Positron Emission Tomography/Magnetic Resonance Imaging
    Ishii, Shiro
    Miyajima, Masayuki
    Suenaga, Hiroki
    Sugawara, Shigeyasu
    Nemoto, Ayaka
    Ukon, Naoyuki
    Nambu, Takeyuki
    Kubo, Hitoshi
    Oriuchi, Noboru
    Ito, Hiroshi
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2019, 43 (04) : 664 - 670